Tegaserod
FDA Approved
Description
Tegaserod is a serotonin-4 (5-HT4) receptor agonist used for the short-term treatment of irritable bowel syndrome with constipation (IBS-C) in women. It may be used off-label for intestinal benign neoplasm related constipation.
Indications & Therapeutic Use
Irritable bowel syndrome with constipation
Linked Diseases:
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Tegaserod
| Generic Name | Tegaserod |
| Brands | 1 brand available |
| Active Ingredient | Tegaserod |
| Drug Class | Irritable bowel syndrome with constipation |
| Manufacturer | Novartis |
| Dosage Forms | Tablet |
| Medical Code | A06AX04 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes